Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × treosulfan × Clear all

NCT01063647 2023-11-03

Dose-range Finding Treosulfan-based Conditioning

Phase 1/2 Completed

Other hematologic neoplasm

Hematologic Neoplasms